Back to search

Flip flop policy over pioglitazone licence causes media storm in India

Soumyadeep Bhaumik
DOI: 10.1136/bmj.f4937
BMJ

Data up to Jan 2025

Published2013
Citations3
References1
Fields
Political scienceMedicineHistoryPhilosophyPublic administrationLawAncient history

Total Citations Per Year

Abstract

References (1)

India's health ministry bans pioglitazone, metamizole, and flupentixol-melitracen

2013 • 25 citations

Cited By (0)

No citing papers found in database

Flip flop policy over pioglitazone licence causes media storm in India (2013) – BMJ | Metascience Observatory Explorer